Integra Lifesciences Files for $450M Senior Notes
Integra Lifesciences filed an indenture for the offer and sale of $450 million in 9.500% Senior Secured Notes due 2033, governed by a Trust Indenture Act. This debt offering is a common capital markets activity used by the company.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed